Article Information
History
- October 5, 2021.
Article Versions
- Version 1 (September 29, 2021 - 09:07).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Charlotte B. Acharya1,
- John Schrom2,
- Anthea M. Mitchell3,
- David A. Coil1,
- Carina Marquez2,4,
- Susana Rojas2,
- Chung Yu Wang3,
- Jamin Liu5,
- Genay Pilarowski2,6,
- Leslie Solis1,
- Elizabeth Georgian1,
- Maya Petersen2,7,#,
- Joseph DeRisi3,#,
- Richard Michelmore1,* and
- Diane Havlir2,4,*
- 1Genome Center, University of California, Davis, USA
- 2Unidos en Salud, San Francisco, CA, USA
- 3Chan Zuckerberg Biohub, and Dept of Biochemistry & Biophysics, University of California, San Francisco, USA
- 4Department of Medicine, Division of HIV, Infectious Disease and Global Medicine, University of California, San Francisco, USA
- 5Joint UCB/UCSF Bioengineering Program, University of California, Berkeley and University of California, San Francisco, USA
- 6The Public Health Company, Oakland, California, USA
- 7School of Public Health, University of California, Berkeley, USA
Posted October 05, 2021.
No Significant Difference in Viral Load Between Vaccinated and Unvaccinated, Asymptomatic and Symptomatic Groups When Infected with SARS-CoV-2 Delta Variant
